IL6 and type 2 diabetes mellitus: The persistent hyperglycaemia can alter the release and functionality of inflammatory cytokines like interleukin 1 (IL-1), interleukin 6 (IL-6) and tumour necrosis factor-a (TNF-a) (Degirmenci et al., 2019), leading to an increase in T2DM.